Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04286451 · ClinicalTrials.gov registry record · NA
Effect of Sleep Restriction on Adipose Tissue and Skeletal Muscle Insulin Sensitivity
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04286451 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 14 participants.
The verdict
NCT04286451, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Inadequate sleep is an independent risk factor for metabolic abnormalities (such as obesity, insulin resistance, and hyperglycemia). Women report sleep disruption during the menopause transition (perimenopause) and into the postmenopausal years. Sleep disruption is one of the primary reasons why midlife women seek medical care, with up to 60% reporting significant sleep disturbances (e.g., trouble falling asleep, early morning waking, and hot flashes/night sweats). Despite the majority of women experiencing sleep disruption, no study has investigated the molecular mechanisms linking sleep disruption and the changes in metabolism that coincide with menopause.
Interventions
- BEHAVIORAL Sleep Restriction
- BEHAVIORAL Habitual Sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-07-28 |
| Est. Completion | 2022-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04286451
The ClinicalTrials.gov registry entry for NCT04286451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleep Restriction is the first listed.
NCT04286451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04286451 about?
NCT04286451 is a clinical study titled "Effect of Sleep Restriction on Adipose Tissue and Skeletal Muscle Insulin Sensitivity". Inadequate sleep is an independent risk factor for metabolic abnormalities (such as obesity, insulin resistance, and hyperglycemia). Women report sleep disruption during the menopause transition (perimenopause) and into the postmenopausal years. Sleep disruption is one of the primary reasons why mid...
What is the current status of trial NCT04286451?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-07-28. Estimated completion is 2022-04-13.
What interventions are being tested in trial NCT04286451?
The interventions under investigation include: Sleep Restriction (BEHAVIORAL), Habitual Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT04286451?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.